[Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. pathogenesis and pathophysiology of bone-marrow failure; 4. The molecular pathogenesis of myelofibrosis].
Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Japan.
Akira
A
Kitanaka
Kazuya
K
Shimoda
D000741:Anemia, Aplastic; D000818:Animals; D001855:Bone Marrow Diseases; D000080983:Bone Marrow Failure Disorders; D004268:DNA-Binding Proteins / Q000235:genetics*; D049308:Dioxygenases; D006457:Hemoglobinuria, Paroxysmal / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D048056:Mitogen-Activated Protein Kinase 9 / Q000235:genetics*; D009154:Mutation / Q000235:genetics; D055728:Primary Myelofibrosis / Q000175:diagnosis* / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*
D004268:DNA-Binding Proteins; D011518:Proto-Oncogene Proteins; D049308:Dioxygenases; C541081:TET2 protein, human; D048056:Mitogen-Activated Protein Kinase 9